Scientific Agenda

Thursday, February 9, 2012

Session IA: Oncology Symptom Management Workshop
(parallel to Session IB)
Session moderator: Charles Loprinzi, MD

4:30 pm

Welcome

4:40 pm

Peripheral neuropathy: Prediction, prevention, and palliation
Beth Faiman, RN, MSN, APRN-BC, AOCN

5:00 pm

Management of renal impairment in multiple myeloma
Ravi Vij, MD

5:20 pm

Neurocognitive impairment: Prediction, prevention, and palliation
Jamie S. Myers, PhD, RN, AOCN

5:40 pm

Palliative therapy: Translating the academic experience to the community setting
Egidio Del Fabbro, MD

6:00 pm

Aromatase inhibitor-associated arthralgias
Charles L. Loprinzi, MD

6:20 pm

Prevention, detection, and management of thromboembolic disorders in the cancer patient
Howard A. Liebman, MD

6:40 pm

Faculty panel
Panel moderator: Charles L. Loprinzi, MD
Panel: Egidio Del Fabbro, MD; Beth Faiman, RN, MSN, APRN-BC, AOCN; Howard A. Liebman, MD; Jamie S. Myers, PhD, RN, AOCN and Ravi Vij, MD

7:00 pm

Adjourn

Session IB: Lymphoma-Myeloma Update
(parallel to Session IA)
Session moderator: Morton Coleman, MD

4:30 pm

Welcome

4:35 pm

Multiple myeloma
Rafael Fonseca, MD

5:00 pm

Waldenstrom’s & amyloidosis: Integrating novel agents into management strategies
Steven P. Treon, MD, PhD

5:25 pm

B-cell lymphomas: Novel agents coming to a clinic near you
Morton Coleman, MD

5:50 pm

T-cell lymphomas: An algorithm for management of advanced disease
Owen A. O’Connor, MD, PhD

6:15 pm

Hodgkins lymphoma: Advances in the management of relapsed and refractory disease
Kerry Savage, MD

6:40 pm

Faculty Panel
Panel moderator: Morton Coleman, MD;
Panel: Rafael Fonseca, MD; Owen A. O’Connor, MD, PhD; Kerry Savage, MD and Steven P. Treon, MD, PhD

7:00 pm

Adjourn

 

Friday, February 10, 2012

8:00 am

Welcome

Session II: Women’s Issues
Session moderator: Christy A. Russell, MD

8:05 am

Early stage breast cancer: An algorithm for personalized therapy and long term monitoring for relapse
Christy A. Russell, MD

8:30 am

Ovarian cancer: 2012 algorithm for management of advanced disease
Bradley Monk, MD, FACOG, FACS

8:55 am

Lung cancer and gender
Anne Tsao, MD

9:20 am

Cancer and pregnancy: Concerns, care, and caveats
Bradley Monk, MD, FACOG, FACS

9:45 am

Coffee break

Session III: Genitourinary Malignancies
Session moderator: Robert Dreicer, MD, FACP

10:15 am

Renal cell cancer: Integrating novel agents into a therapeutic algorithm
Jorge A. Garcia, MD, FACP

10:40 am

Prostate cancer: Role of systemic therapy in high risk and locally advanced disease
Robert Dreicer, MD, FACP

11:05 am

Castrate resistance prostate cancer: Integrating novel agents into a therapeutic algorithm
Charles J. Ryan, MD

11:30 am

Luncheon symposium:
Molecular Profiling and Personalized Therapies: A Paradigm Shift in Lung Cancer Management
Supported by: Genentech

Session IV: Gastrointestinal Malignancies: Challenging Cases and Practice Pearls
Session moderator: David Ilson, MD, PhD

1:00 pm

Upper GI cancers and pancreas: Risk stratification and treatment selection
David Ilson, MD, PhD

1:25 pm

Colon cancer: Combining molecular diagnostics and the art of medicine in the long term management of advanced colon cancer
J. Randolph Hecht, MD

1:50 pm

Neuroendocrine tumors and HCC
Alan P. Venook, MD

2:15 pm

Faculty Panel
Panel moderator: David H. Ilson, MD, PhD
Panel: J. Randolph Hecht, MD and Alan P. Venook, MD

2:30 pm

Coffee break

Session V: Breast Cancer
Session moderator: James Epstein, MD

2:50 pm

Advanced stage breast cancer: Strategic use of available agents through multiple lines of therapy for advanced ER/PR-negative disease
Harold J. Burstein, MD, PhD

Session VI: Novel Anti-Coagulats and the Oncologist
Session moderator: James Epstein, MD

3:15 pm

Novel anti-coagulants and the oncologist
Howard A. Liebman, MD

3:45 pm

Adjourn

 

Saturday, February 11, 2012

8:00 am

Welcome

Session VII: Lung Cancer
Session moderator: Corey J. Langer, MD, FACP

8:10 am

Personalizing frontline therapy for advanced non-squamous non-small cell lung carcinoma: The role of molecular profiling in community practice
Barbara J. Gitlitz, MD

8:40 am

Maintenance therapy: Who, when, what, and for how long?
Anne S. Tsao, MD

9:10 am

Second and third line therapy: Developing an algorithm for clinical practice
Corey J. Langer, MD, FACP

9:40 am

Faculty Panel
Panel Moderator: Corey J. Langer, MD, FACP
Panel: Barbara J. Gitlitz, MD and Anne S. Tsao, MD

10:00 am

Coffee break

Session VIII: Uncommon Malignancies
Session moderator: James Epstein, MD

10:30 am

Update in sarcoma management and GIST
Shreyaskumar Patel, MD

11:05 am

Advances in glioma therapy
David A. Reardon, MD

11:40 am

Head and neck and thyroid cancers
Corey J. Langer, MD, FACP

12:15 pm

Malignant melanoma: Paradigm shift in management of advanced disease
Antoni Ribas, MD

12:45 pm

Lunch

Session IX: Myeloid Malignancies and Chronic Lymphocytic Leukemia
Session moderator: David P. Steensma, MD

1:45 pm

MDS and MPN: Some things old and some things new
David P. Steensma, MD

2:15 pm

CML: Management algorithm for a chronic disease
David P. Steensma, MD

2:45 pm

CLL: Integrating novel therapies into frontline and salvage regimens
Michael J. Keating, MB, BS

3:15 pm

Adjourn